Table 5.

Functional outcome at 90 days (mRS90d 0–2 vs. 3–6) and procedural parameters.

		n	%	mRS 0–2	mRS 3–6	OR (95%-KI)	p-value*	p-value**
Time to recanalization [h]	≤ 6 h	66	28.6	39 (59.1%)	27 (40.9%)	Ref.	0.025
	>6 h	165	71.4	124 (75.2%)	41 (24.8%)	0.48 (0.26–0.88)
Witnessed	Non-witnessed	82	35.5	64 (78.0%)	18 (22.0%)	Ref.	0.071
	Witnessed	149	64.5	99 (66.4%)	50 (33.6%)	1.80 (0.96–3.36)
≤ 6 h	Witnessed	65	100.0	38 (58.5%)	27 (41.5%)
>6 h	Non-witnessed	82	49.4	64 (78.0%)	18 (22.0%)	Ref.	0.474
	Witnessed	84	50.6	61 (72.6%)	23 (27.4%)	1.34 (0.66–2.73)
Duration of	<1 h	81	35.4	53 (65.4%)	28 (34.6%)	Ref.	0.256
Treat. [h]	≥1 h	88	38.4	62 (70.5%)	26 (29.5%)	0.79 (0.41–1.52)		0.512
	≥2	60	26.2	47 (78.3%)	13 (21.7%)	0.52 (0.24–1.13)		0.133
Year of treatment	2008–2010	36	15.6	32 (88.9%)	4 (11.1%)	Ref.	0.009
	2011–2019	195	84.4	131 (67.2%)	64 (32.8%)	3.91 (1.32–11.55)

^*Global p-value,

^**p-value for each subgroup if exceeding more than two subgruops.